ATOSSA THERAPEUTICS, INC. Quarterly Return On Assets in % from Q2 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Atossa Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2013 to Q3 2024.
  • Atossa Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -30.5 %, a 15% decline year-over-year.
  • Atossa Therapeutics, Inc. annual Return On Assets for 2023 was -28.5 %, a 37.8% decline from 2022.
  • Atossa Therapeutics, Inc. annual Return On Assets for 2022 was -20.7 %, a 43.2% decline from 2021.
  • Atossa Therapeutics, Inc. annual Return On Assets for 2021 was -14.4 %, a 84.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -30.5 -3.99 -15% Jul 1, 2024 Sep 30, 2024
Q2 2024 -27.7 -1.01 -3.79% Apr 1, 2024 Jun 30, 2024
Q1 2024 -29.9 -7.15 -31.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -28.5 -7.82 -37.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -26.5 -8.51 -47.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -26.6 -11.2 -72.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -22.7 -7.34 -47.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -20.7 -6.24 -43.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -18 +1.66 +8.44% Jul 1, 2022 Sep 30, 2022
Q2 2022 -15.5 +9.8 +38.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -15.4 +20.4 +57% Jan 1, 2022 Mar 31, 2022
Q4 2021 -14.4 +79 +84.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -19.7 +88.5 +81.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -25.3 +70.8 +73.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -35.8 +69 +65.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -93.5 +4.04 +4.14% Oct 1, 2020 Dec 31, 2020
Q3 2020 -108 -9.84 -10% Jul 1, 2020 Sep 30, 2020
Q2 2020 -96.1 +6.07 +5.94% Apr 1, 2020 Jun 30, 2020
Q1 2020 -105 -19 -22.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -97.5 -3.26 -3.46% Oct 1, 2019 Dec 31, 2019
Q3 2019 -98.3 +2.66 +2.64% Jul 1, 2019 Sep 30, 2019
Q2 2019 -102 +16.5 +13.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -85.8 +61.8 +41.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -94.3 +78.5 +45.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -101 +133 +56.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -119 +25 +17.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -148 -3.99 -2.78% Jan 1, 2018 Mar 31, 2018
Q4 2017 -173 -37.3 -27.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -234 -65.5 -38.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -144 +53.9 +27.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -144 +3.04 +2.07% Jan 1, 2017 Mar 31, 2017
Q4 2016 -135 -6.71 -5.21% Oct 1, 2016 Dec 31, 2016
Q3 2016 -169 -46.6 -38.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -198 -92.1 -87.2% Apr 1, 2016 Jun 30, 2016
Q1 2016 -147 -46.3 -46.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -129 -45.9 -55.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -122 -56.6 -86.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -106 -35.5 -50.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -100 -22.6 -29% Jan 1, 2015 Mar 31, 2015
Q4 2014 -82.9 +14.2 +14.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -65.4 +33.7 +34% Jul 1, 2014 Sep 30, 2014
Q2 2014 -70.1 +23.6 +25.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -77.7 Jan 1, 2014 Mar 31, 2014
Q4 2013 -97 Oct 1, 2013 Dec 31, 2013
Q3 2013 -99.1 Jul 1, 2013 Sep 30, 2013
Q2 2013 -93.7 Apr 1, 2013 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.